samedan logo
home > events calendar > more about event

BioProcess International Conference & Exhibition (BPI)

BioProcess International Conference & Exhibition (BPI)

25-28 September 2017
Hynes Convention Center, Boston, Massachusetts, USA

BioProcess International Conference & Exhibition (BPI) is the largest bioprocessing event bringing you the science, technologies and partners needed to accelerate promising biologics towards commercial success.  Join 1800+ global bioprocessing professionals at this year’s meeting, held September 25-28, 2017 at the Hynes Convention Center in Boston.  The 2017 scientific agenda covers important industry updates and new data across entire bioprocessing spectrum, from early stage process development through late stage commercial manufacturing.  We are pleased to announce the confirmation of our first two keynote speakers:

  • Improving Global Access to Biotherapeutics through Molecule, Process and Manufacturing Design: Dean K. Pettit, Ph.D., CSO and Founding Partner, Just Biotherapeutics
  • Tools for Mapping and Repairing Disease States: Can We Make Therapeutic Invention into a Mature Design Science?: Ed Boyden, Ph.D., Associate Professor, Media Lab and McGovern Institute, MIT

Readers of European Biopharmaceutical Review can receive a 10% registration discount off current rates by registering with VIP code EBR10 online at (new registrations only).  If you have any questions about participating at this year’s meeting, please contact Event Marketing Manager Howie Choi at

email Howie Choi:
email Hynes Convention Center, Boston, Massachusetts, USA
Print this page
Send to a friend
Industry Events

5th Biennial Biosimilars & Biobetters Congress 2018

16-17 April 2018, Novotel London West Hotel, Hammersmith, London

Oxford Global are proud to present our highly anticipated 5thBiennial Biosimilars & Biobetters Congress, 16th – 17thApril 2018, London, UK. Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions will enjoy over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics
More info >>

Banner of DIA_events_95 on Samedan

White Papers

High Potency Drugs – from Molecule to Market

PCI Pharma Services

PCI Pharma Services has invested in state-of-the-art containment equipment and created a ‘Potent Passport’ philosophy to identify the specific handling requirements for any Highly Potent Active Pharmaceutical Ingredients (HPAPI) project. Backed by 30 years’ experience of managing potent molecules, PCI Pharma Services is the logical choice when selecting an outsourcing partner.
More info >>

News and Press Releases

Merck Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables

More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement